FDA Adverse Event Malfunction Summary report: N

UNSPECIFIED CADD MEDICATION CASSETTE

MDR report key: 21118830 · Received January 9, 2025

Report

Report Number
3012307300-2025-00541
Event Type
Malfunction
Date Received
January 9, 2025
Date of Event
December 1, 2024
Report Date
January 9, 2025
Manufacturer
SMITHS MEDICAL ASD, INC.
Product Code
FPA
PMA / PMN Number
UNKNOWN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

E1: INITIAL REPORTER FACILITY NAME: (B)(6). H3, H6: NO PRODUCT WAS RETURNED. THE REPORTED COMPLAINT COULD NOT BE CONFIRMED. IF THE PRODUCT IS RETURNED THIS COMPLAINT WILL BE REOPENED FOR FURTHER INVESTIGATION. A DEVICE HISTORY RECORD (DHR) REVIEW WAS NOT CONDUCTED AS THERE WAS NO LOT NUMBER PROVIDED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE CASSETTE FROM THE PATIENT¿S LAST ORDER LEAKED MEDICATION. THE PATIENT BEGAN THERAPY WITH REMODULIN (TREPROSTINIL SODIUM, CONCENTRATION 10.0 MG/ML) DELIVERED VIA A SELF-FILLED PUMP. THE CURRENT DOSE WAS REPORTED AS 0.082 G/KG, SELF-FILLED WITH 3 ML PER CASSETTE AT A PUMP RATE OF 38 MCL/HOUR, CONTINUOUS VIA SUBCUTANEOUS (SQ) ROUTE. THERE WAS PATIENT INVOLVEMENT AND UNKNOWN SIGNS OR SYMPTOMS EXPERIENCED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1169736 UNSPECIFIED CADD MEDICATION CASSETTE SET, ADMINISTRATION, INTRAVASCULAR FPA SMITHS MEDICAL ASD, INC. NI

Patients

Seq Age Sex Outcome Treatment
1 71 YR Female ALBUTEROL SULFATE HFA| ALLOPURINOL| AMITRIPTYLINE| ATORVASTATIN CALCIUM| BUMETANIDE| CINACALCET| CLEO INFUSION SET| CLONIDINE| FISH OIL| GABAPENTIN| GLIPIZIDE| KETAMINE| KETOPROFEN| LECITHIN| LIDOCAINE| LOPERAMIDE| METOPROLOL SUCCINATE| MULTIVITAMIN| OXYGEN| POLOXAMER| POTASSIUM CHLORIDE| REMODULIN (TREPROSTINIL SODIUM) SQ ROUTE10.0 MG/ML| REMUNITY PUMP| SILDENAFIL CITRATE| TYLENOL (PARACETAMOL)| WARFARIN SODIUM| ZYRTEC (CETIRIZINE HYDROCHLORIDE)